Rinda Sama - Jun 8, 2021 Form 4 Insider Report for Axonics, Inc. (AXNX)

Role
Chief Operating Officer
Signature
/s/ Dan Dearen, as Attorney-in-Fact for Rinda Sama
Stock symbol
AXNX
Transactions as of
Jun 8, 2021
Transactions value $
-$108,464
Form type
4
Date filed
6/10/2021, 09:38 PM
Previous filing
May 13, 2021
Next filing
Jun 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Options Exercise $14.2K +1K +3.46% $14.19* 29.9K Jun 8, 2021 Direct
transaction AXNX Common Stock Sale -$60.2K -1K -3.34% $60.23 28.9K Jun 8, 2021 Direct F1, F2
transaction AXNX Common Stock Options Exercise $19.3K +1.36K +4.71% $14.19* 30.3K Jun 10, 2021 Direct
transaction AXNX Common Stock Sale -$81.7K -1.36K -4.5% $60.02 28.9K Jun 10, 2021 Direct F1, F3
holding AXNX Common Stock 4K Jun 8, 2021 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -1K -2.41% $0.00 40.6K Jun 8, 2021 Common Stock 1K $14.19 Direct F4
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -1.36K -3.36% $0.00 39.2K Jun 10, 2021 Common Stock 1.36K $14.19 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $60.20 to $60.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $60.00 to $60.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 30th, 2020, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 30th, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.